Literature DB >> 21232166

The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.

Swen Hesse1, Katarina Stengler, Ralf Regenthal, Marianne Patt, Georg-Alexander Becker, Annegret Franke, Heike Knüpfer, Philipp M Meyer, Julia Luthardt, Ina Jahn, Donald Lobsien, Wolfgang Heinke, Peter Brust, Ulrich Hegerl, Osama Sabri.   

Abstract

The pathogenetic role of central serotonin transporters (SERT) in obsessive-compulsive disorder (OCD) has been investigated in vivo by positron emission tomography (PET) or single-photon emission computed tomography (SPECT) studies with inconsistent results. This might reflect methodological differences but possibly also the pathophysiological heterogeneity of the disorder, i.e. the age at onset of OCD. The aim of our study was to compare SERT availability in patients with OCD to healthy controls (HC) taking into account the onset type, other factors and covariates (e.g. SERT genotype, age, depression level, gender). We studied 19 drug-naive OCD patients (36±13 yr, eight females) with early onset (EO-OCD, n=6) or with late onset (LO-OCD, n=13), and 21 HC (38±8 yr, nine females) with PET and the SERT-selective radiotracer [11C]DASB. Statistical models indicated that a variety of covariates and their interaction influenced SERT availability measured by distribution volume ratios (DVR). These models revealed significant effects of onset type on DVR with lower values in LO-OCD (starting at age 18 yr) compared to EO-OCD and HC in limbic (e.g. the amygdala), paralimbic brain areas (the anterior cingulate cortex), the nucleus accumbens and striatal regions, as well as borderline significance in the thalamus and the hypothalamus. The putamen, nucleus accumbens and hypothalamus were found with significant interaction between two SERT gene polymorphisms (SERT-LPR and VNTR). These findings suggest that late but not early onset of OCD is associated with abnormally low SERT availability. In part, functional polymorphisms of the SERT gene might determine the differences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232166     DOI: 10.1017/S1461145710001604

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  18 in total

1.  Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.

Authors:  Sophia Attwells; Elaine Setiawan; Alan A Wilson; Pablo M Rusjan; Romina Mizrahi; Laura Miler; Cynthia Xu; Margaret Anne Richter; Alan Kahn; Stephen J Kish; Sylvain Houle; Lakshmi Ravindran; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2017-08-01       Impact factor: 21.596

2.  Altered serotonin transporter availability in patients with multiple sclerosis.

Authors:  Swen Hesse; Franziska Moeller; David Petroff; Donald Lobsien; Julia Luthardt; Ralf Regenthal; Georg-Alexander Becker; Marianne Patt; Eva Thomae; Anita Seese; Philipp M Meyer; Florian Then Bergh; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

3.  Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Vibe G Frokjaer; Douglas N Greve; Stephen C Strother; Gitte M Knudsen
Journal:  Neuroimage       Date:  2019-06-01       Impact factor: 6.556

4.  Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Authors:  Dafna Lotan; Itai Benhar; Kathy Alvarez; Adita Mascaro-Blanco; Lior Brimberg; Dan Frenkel; Madeleine W Cunningham; Daphna Joel
Journal:  Brain Behav Immun       Date:  2014-02-20       Impact factor: 7.217

5.  False positive rates in positron emission tomography (PET) voxelwise analyses.

Authors:  Melanie Ganz; Martin Nørgaard; Vincent Beliveau; Claus Svarer; Gitte M Knudsen; Douglas N Greve
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-26       Impact factor: 6.200

6.  Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.

Authors:  Swen Hesse; Peter Brust; Peter Mäding; Georg-Alexander Becker; Marianne Patt; Anita Seese; Dietlind Sorger; Jörg Zessin; Philipp M Meyer; Donald Lobsien; Sven Laudi; Bernd Habermann; Frank Füchtner; Julia Luthardt; Anke Bresch; Jörg Steinbach; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-17       Impact factor: 9.236

7.  Reduced fronto-callosal fiber integrity in unmedicated OCD patients: a diffusion tractography study.

Authors:  Jungsu S Oh; Joon Hwan Jang; Wi Hoon Jung; Do-Hyung Kang; Jung-Seok Choi; Chi-Hoon Choi; Marek Kubicki; Martha E Shenton; Jun Soo Kwon
Journal:  Hum Brain Mapp       Date:  2011-09-16       Impact factor: 5.038

8.  Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.

Authors:  Jesse Wood; Zoe LaPalombara; Susanne E Ahmari
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

9.  Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.

Authors:  Marjan Biria; Lucia-Manuela Cantonas; Paula Banca
Journal:  Curr Top Behav Neurosci       Date:  2021

10.  Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.

Authors:  Swen Hesse; Michael Rullmann; Julia Luthardt; Karsten Winter; Mohammed K Hankir; Georg-Alexander Becker; Franziska Zientek; Georg Reissig; Ralf Regenthal; Mandy Drabe; Christian Schinke; Anke Bresch; Katrin Arelin; Donald Lobsien; Marianne Patt; Philipp M Meyer; Mathias Fasshauer; Wiebke K Fenske; Matthias Blüher; Michael Stumvoll; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.